Drugs / NNC0174-1213
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06719011 | Dec 2024 → Mar 2026 overdue | obesity disorder | Novo Nordisk A/S | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NNC0174-1213 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06719011 ↗ |
| Route | Subcutaneous | “administered as subcutaneous (s.c. under the skin) injection” NCT06719011 ↗ |